Etude de l'AG du 16/05/2017
En application de la loi Sapin II, la société soumet la politique de rémunération de Michele Garufi, Président-Directeur général, au titre de l'exercice 2017 au vote de l'assemblée générale. Les principales faiblesses de celle-ci consistent en l'absence de rémunération de long-terme et le manque de transparence sur les conditions de performance du bonus annuel et de la rémunération actionnariale. Cependant, Michele Garufi étant un important actionnaire (233 051 actions), ses intérêts semblent être alignés sur ceux des actionnaires. Dans ce contexte, nous recommandons l'approbation à la résolution 11.
Le renouvellement d'Ernst&Young en tant que commissaire au compte titulaire ne sera pas soutenu en raison de l'ancienneté du mandat et d'honoraires non liés directement aux missions d'audit trop élevés (Résolution 10).
La plupart des résolutions d'ordre extraordinaire ne seront également pas approuvées car elles correspondent principalement à des autorisations d'augmentation de capital non suspendues en période d'offre publique avec des montants demandés trop élevés.
Nicox is engaged in the ophthalmic market. Co. markets several ophthalmic products in the United States and Europe with a portfolio of therapies and diagnostic tools that can help people to enhance their sight. Co. has developed naproxcinod, the first member of the Cyclooxygenase-Inhibiting Nitric Oxide-Donating (CINOD) class of anti-inflammatory agents, for the treatment of the signs and symptoms of osteoarthritis. Beyond naproxcinod, Co. has a pipeline containing multiple nitric oxide-donating NCEs, which are in clinical development with partners for the treatment of diseases, such as hypertension, glaucoma and Chronic Obstructive Pulmonary Disease (COPD).
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
- Proxy reports
- Definition and monitoring of client customized voting guidelines
- Corporate Governance Data and Rating
- Thematic research
- Engagement support
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.